These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26151783)

  • 1. Severe Autoimmune Adverse Events Post Herpes Zoster Vaccine: A Case-Control Study of Adverse Events in a National Database.
    Lai YC; Yew YW
    J Drugs Dermatol; 2015 Jul; 14(7):681-4. PubMed ID: 26151783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events.
    Geier DA; Geier MR
    Clin Rheumatol; 2015 Jul; 34(7):1225-31. PubMed ID: 25535199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination: a new option to reduce the burden of herpes zoster.
    Mick G
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination to prevent herpes zoster in older adults.
    Gnann JW
    J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herpes zoster vaccine: clinical trial evidence and implications for medical practice.
    Burke MS
    J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.
    Tyring SK; Diaz-Mitoma F; Padget LG; Nunez M; Poland G; Cassidy WM; Bundick ND; Li J; Chan IS; Stek JE; Annunziato PW;
    Vaccine; 2007 Feb; 25(10):1877-83. PubMed ID: 17227688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database.
    Geier DA; Geier MR
    Immunol Res; 2017 Feb; 65(1):46-54. PubMed ID: 27406735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
    Lal H; Cunningham AL; Godeaux O; Chlibek R; Diez-Domingo J; Hwang SJ; Levin MJ; McElhaney JE; Poder A; Puig-Barberà J; Vesikari T; Watanabe D; Weckx L; Zahaf T; Heineman TC;
    N Engl J Med; 2015 May; 372(22):2087-96. PubMed ID: 25916341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoster vaccine live.
    Kockler DR; McCarthy MW
    Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study.
    Tseng HF; Liu A; Sy L; Marcy SM; Fireman B; Weintraub E; Baggs J; Weinmann S; Baxter R; Nordin J; Daley MF; Jackson L; Jacobsen SJ;
    J Intern Med; 2012 May; 271(5):510-20. PubMed ID: 22026504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of herpes zoster by vaccination].
    Kofoed K; Rønholt F; Gerstoft J; Sand C
    Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review.
    Geier MR; Geier DA
    Clin Exp Rheumatol; 2004; 22(6):749-55. PubMed ID: 15638050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes zoster vaccination: benefits and barriers.
    Komara FA
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S22-4. PubMed ID: 19553633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why should older adults receive the shingles vaccine?
    Harkness TL
    J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
    Mills R; Tyring SK; Levin MJ; Parrino J; Li X; Coll KE; Stek JE; Schlienger K; Chan IS; Silber JL
    Vaccine; 2010 Jun; 28(25):4204-9. PubMed ID: 20416263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes zoster vaccine. Poorly effective in those who need it most.
    Prescrire Int; 2012 Dec; 21(133):291. PubMed ID: 23373094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Prevention of Herpes Zoster Reactivation in Patients with Autoimmune Diseases.
    Chakravarty EF
    Rheum Dis Clin North Am; 2017 Feb; 43(1):111-121. PubMed ID: 27890168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.